PRJDB7713: Age associated transcriptome analysis in 5 tissues of zebrafish
Gene Symbol | Gene ID | Gene Info |
---|---|---|
myod1
|
ENSDARG00000030110 | myogenic differentiation 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
myod1 | dr11_v1_chr25_-_31423493_31423493 | 0.78 | 4.2e-20 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_32817274 | 47.40 |
ENSDART00000142582
|
mylpfa
|
myosin light chain, phosphorylatable, fast skeletal muscle a |
chr8_-_1051438 | 35.50 |
ENSDART00000067093
ENSDART00000170737 |
smyd1b
|
SET and MYND domain containing 1b |
chr6_-_42003780 | 31.49 |
ENSDART00000032527
|
cav3
|
caveolin 3 |
chr3_+_32526263 | 29.90 |
ENSDART00000150897
|
si:ch73-367p23.2
|
si:ch73-367p23.2 |
chr2_+_55982940 | 28.12 |
ENSDART00000097753
ENSDART00000097751 |
nmrk2
|
nicotinamide riboside kinase 2 |
chr3_+_32526799 | 26.92 |
ENSDART00000185755
|
si:ch73-367p23.2
|
si:ch73-367p23.2 |
chr22_-_14128716 | 26.37 |
ENSDART00000140323
|
si:ch211-246m6.4
|
si:ch211-246m6.4 |
chr21_+_27382893 | 25.57 |
ENSDART00000005682
|
actn3a
|
actinin alpha 3a |
chr2_+_55982300 | 24.42 |
ENSDART00000183903
|
nmrk2
|
nicotinamide riboside kinase 2 |
chr7_+_31891110 | 23.10 |
ENSDART00000173883
|
mybpc3
|
myosin binding protein C, cardiac |
chr9_-_22831836 | 22.77 |
ENSDART00000142585
|
neb
|
nebulin |
chr6_-_39764995 | 22.39 |
ENSDART00000085277
|
pfkmb
|
phosphofructokinase, muscle b |
chr9_-_7539297 | 21.77 |
ENSDART00000081550
ENSDART00000081553 |
desma
|
desmin a |
chr6_+_3680651 | 21.15 |
ENSDART00000013588
|
klhl41b
|
kelch-like family member 41b |
chr12_-_4070058 | 20.04 |
ENSDART00000042200
|
aldoab
|
aldolase a, fructose-bisphosphate, b |
chr8_-_11229523 | 19.98 |
ENSDART00000002164
|
unc45b
|
unc-45 myosin chaperone B |
chr13_+_22264914 | 19.91 |
ENSDART00000060576
|
myoz1a
|
myozenin 1a |
chr18_+_402048 | 19.80 |
ENSDART00000166345
|
gpib
|
glucose-6-phosphate isomerase b |
chr9_-_98982 | 19.66 |
ENSDART00000147882
|
lims2
|
LIM and senescent cell antigen-like domains 2 |
chr2_-_44255537 | 19.48 |
ENSDART00000011188
ENSDART00000093298 |
atp1a2a
|
ATPase Na+/K+ transporting subunit alpha 2 |
chr18_-_6634424 | 19.27 |
ENSDART00000062423
ENSDART00000179955 |
tnni1c
|
troponin I, skeletal, slow c |
chr7_-_69857692 | 18.64 |
ENSDART00000124764
|
myoz2a
|
myozenin 2a |
chr16_-_31469065 | 18.35 |
ENSDART00000182397
|
si:ch211-251p5.5
|
si:ch211-251p5.5 |
chr22_-_651719 | 17.99 |
ENSDART00000148692
|
apobec2a
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a |
chr9_-_48281941 | 17.89 |
ENSDART00000099787
|
klhl41a
|
kelch-like family member 41a |
chr13_-_7031033 | 17.70 |
ENSDART00000193211
|
CABZ01061524.1
|
|
chr25_+_14087045 | 17.65 |
ENSDART00000155770
|
actc1c
|
actin, alpha, cardiac muscle 1c |
chr2_-_21335131 | 17.56 |
ENSDART00000057022
|
klhl40a
|
kelch-like family member 40a |
chr12_-_26415499 | 17.55 |
ENSDART00000185779
|
synpo2lb
|
synaptopodin 2-like b |
chr17_+_27434626 | 17.25 |
ENSDART00000052446
|
vgll2b
|
vestigial-like family member 2b |
chr24_-_33703504 | 17.20 |
ENSDART00000079292
|
cavin4b
|
caveolae associated protein 4b |
chr6_-_39765546 | 17.20 |
ENSDART00000185767
|
pfkmb
|
phosphofructokinase, muscle b |
chr7_+_39402864 | 16.81 |
ENSDART00000025852
|
tnni2b.1
|
troponin I type 2b (skeletal, fast), tandem duplicate 1 |
chr20_-_27325258 | 16.50 |
ENSDART00000152917
|
asb2a.1
|
ankyrin repeat and SOCS box containing 2a, tandem duplicate 1 |
chr20_+_26966725 | 16.17 |
ENSDART00000029781
|
ahsa1a
|
AHA1, activator of heat shock protein ATPase homolog 1a |
chr14_+_31651533 | 15.97 |
ENSDART00000172835
|
fhl1a
|
four and a half LIM domains 1a |
chr16_-_12723738 | 15.96 |
ENSDART00000080414
|
sbk3
|
SH3 domain binding kinase family, member 3 |
chr23_-_5683147 | 15.28 |
ENSDART00000102766
ENSDART00000067351 |
tnnt2a
|
troponin T type 2a (cardiac) |
chr20_-_38758797 | 14.70 |
ENSDART00000061394
|
trim54
|
tripartite motif containing 54 |
chr7_+_31879649 | 13.96 |
ENSDART00000099789
|
mybpc3
|
myosin binding protein C, cardiac |
chr4_+_7841627 | 13.84 |
ENSDART00000037997
|
ucmaa
|
upper zone of growth plate and cartilage matrix associated a |
chr23_-_32194397 | 13.61 |
ENSDART00000184206
ENSDART00000166682 |
nr4a1
|
nuclear receptor subfamily 4, group A, member 1 |
chr22_-_26595027 | 13.26 |
ENSDART00000184162
|
CABZ01072309.1
|
|
chr24_+_20575259 | 13.22 |
ENSDART00000010488
|
klhl40b
|
kelch-like family member 40b |
chr16_-_14074594 | 13.10 |
ENSDART00000090234
|
trim109
|
tripartite motif containing 109 |
chr23_+_44614056 | 13.09 |
ENSDART00000188379
|
eno3
|
enolase 3, (beta, muscle) |
chr22_+_16308450 | 12.97 |
ENSDART00000105678
|
lrrc39
|
leucine rich repeat containing 39 |
chr20_+_26967154 | 12.90 |
ENSDART00000153294
ENSDART00000132434 ENSDART00000143047 |
ahsa1a
|
AHA1, activator of heat shock protein ATPase homolog 1a |
chr4_-_16354292 | 12.76 |
ENSDART00000139919
|
lum
|
lumican |
chr20_-_21672970 | 12.75 |
ENSDART00000133286
|
si:ch211-207i1.2
|
si:ch211-207i1.2 |
chr14_+_31657412 | 12.41 |
ENSDART00000105767
|
fhl1a
|
four and a half LIM domains 1a |
chr22_+_16308806 | 12.39 |
ENSDART00000162685
|
lrrc39
|
leucine rich repeat containing 39 |
chr18_+_29145681 | 12.30 |
ENSDART00000089031
ENSDART00000193336 |
ppfibp2a
|
PTPRF interacting protein, binding protein 2a (liprin beta 2) |
chr3_+_49397115 | 12.29 |
ENSDART00000176042
|
tecra
|
trans-2,3-enoyl-CoA reductase a |
chr7_+_31838320 | 12.19 |
ENSDART00000144679
ENSDART00000174217 ENSDART00000122506 |
mybpc3
|
myosin binding protein C, cardiac |
chr7_+_31879986 | 12.17 |
ENSDART00000138491
|
mybpc3
|
myosin binding protein C, cardiac |
chr2_-_42128714 | 12.03 |
ENSDART00000047055
|
trim55a
|
tripartite motif containing 55a |
chr1_-_38816685 | 11.94 |
ENSDART00000075230
|
asb5b
|
ankyrin repeat and SOCS box containing 5b |
chr11_-_45171139 | 11.85 |
ENSDART00000167036
ENSDART00000161712 ENSDART00000158156 |
syngr2b
|
synaptogyrin 2b |
chr14_+_22113331 | 11.63 |
ENSDART00000109759
|
tmx2a
|
thioredoxin-related transmembrane protein 2a |
chr12_+_18524953 | 11.39 |
ENSDART00000090332
|
neurl2
|
neuralized E3 ubiquitin protein ligase 2 |
chr2_-_23768818 | 11.11 |
ENSDART00000148685
ENSDART00000191167 |
xirp1
|
xin actin binding repeat containing 1 |
chr16_-_12723324 | 11.07 |
ENSDART00000131915
|
sbk3
|
SH3 domain binding kinase family, member 3 |
chr23_-_31512496 | 10.84 |
ENSDART00000158755
ENSDART00000143425 |
eya4
|
EYA transcriptional coactivator and phosphatase 4 |
chr6_-_21189295 | 10.73 |
ENSDART00000137136
|
obsl1a
|
obscurin-like 1a |
chr4_-_16412084 | 10.67 |
ENSDART00000188460
|
dcn
|
decorin |
chr23_+_6077503 | 10.54 |
ENSDART00000081714
ENSDART00000139834 |
mybpha
|
myosin binding protein Ha |
chr5_-_64355227 | 10.18 |
ENSDART00000170787
|
fam78aa
|
family with sequence similarity 78, member Aa |
chr14_-_25956804 | 9.94 |
ENSDART00000135627
ENSDART00000146022 ENSDART00000039660 |
sparc
|
secreted protein, acidic, cysteine-rich (osteonectin) |
chr23_-_29003864 | 9.88 |
ENSDART00000148257
|
casz1
|
castor zinc finger 1 |
chr3_+_22242269 | 9.83 |
ENSDART00000168970
|
scn4ab
|
sodium channel, voltage-gated, type IV, alpha, b |
chr19_-_5369486 | 9.72 |
ENSDART00000105004
|
krt17
|
keratin 17 |
chr22_-_10110959 | 9.68 |
ENSDART00000031005
ENSDART00000147580 |
gls2b
|
glutaminase 2b (liver, mitochondrial) |
chr16_+_25245857 | 9.60 |
ENSDART00000155220
|
klhl38b
|
kelch-like family member 38b |
chr20_-_26866111 | 9.14 |
ENSDART00000077767
|
mylk4b
|
myosin light chain kinase family, member 4b |
chr13_+_23157053 | 9.10 |
ENSDART00000162359
|
sorbs1
|
sorbin and SH3 domain containing 1 |
chr25_-_8602437 | 9.07 |
ENSDART00000171200
|
rhcgb
|
Rh family, C glycoprotein b |
chr17_+_38573471 | 8.99 |
ENSDART00000040627
|
sptb
|
spectrin, beta, erythrocytic |
chr17_+_53311618 | 8.91 |
ENSDART00000166517
|
asb2b
|
ankyrin repeat and SOCS box containing 2b |
chr4_-_15603511 | 8.90 |
ENSDART00000122520
ENSDART00000162356 |
chchd3a
|
coiled-coil-helix-coiled-coil-helix domain containing 3a |
chr16_-_29146624 | 8.84 |
ENSDART00000159814
ENSDART00000009826 |
mef2d
|
myocyte enhancer factor 2d |
chr1_-_10841348 | 8.82 |
ENSDART00000148305
|
dmd
|
dystrophin |
chr25_+_16214854 | 8.75 |
ENSDART00000109672
ENSDART00000190093 |
mical2b
|
microtubule associated monooxygenase, calponin and LIM domain containing 2b |
chr24_+_26276805 | 8.73 |
ENSDART00000089749
|
adipoqa
|
adiponectin, C1Q and collagen domain containing, a |
chr19_+_46113828 | 8.72 |
ENSDART00000159331
ENSDART00000161826 |
rbm24a
|
RNA binding motif protein 24a |
chr21_-_35419486 | 8.70 |
ENSDART00000138529
|
si:dkeyp-23e4.3
|
si:dkeyp-23e4.3 |
chr21_+_28749720 | 8.69 |
ENSDART00000145178
|
zgc:100829
|
zgc:100829 |
chr9_-_23944470 | 8.42 |
ENSDART00000138754
|
col6a3
|
collagen, type VI, alpha 3 |
chr14_-_17563773 | 8.32 |
ENSDART00000082667
|
fgfrl1a
|
fibroblast growth factor receptor like 1a |
chr14_+_6159356 | 8.31 |
ENSDART00000157730
|
bscl2l
|
Bernardinelli-Seip congenital lipodystrophy 2, like |
chr7_+_20467549 | 8.27 |
ENSDART00000173724
|
si:dkey-33c9.8
|
si:dkey-33c9.8 |
chr5_-_31904562 | 8.23 |
ENSDART00000140640
|
coro1cb
|
coronin, actin binding protein, 1Cb |
chr6_-_7052408 | 8.23 |
ENSDART00000150033
ENSDART00000149232 |
bin1b
|
bridging integrator 1b |
chr9_-_49531762 | 8.20 |
ENSDART00000121875
|
xirp2b
|
xin actin binding repeat containing 2b |
chr1_+_50293938 | 8.19 |
ENSDART00000084184
|
aimp1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
chr7_-_40578733 | 8.09 |
ENSDART00000173926
ENSDART00000010035 |
dnajb6b
|
DnaJ (Hsp40) homolog, subfamily B, member 6b |
chr6_+_40629066 | 7.99 |
ENSDART00000103757
|
slc6a11a
|
solute carrier family 6 (neurotransmitter transporter), member 11a |
chr3_-_32169754 | 7.93 |
ENSDART00000179010
|
tnnt1
|
troponin T type 1 (skeletal, slow) |
chr6_-_35401282 | 7.90 |
ENSDART00000127612
|
rgs5a
|
regulator of G protein signaling 5a |
chr7_+_65586624 | 7.79 |
ENSDART00000184344
|
mical2a
|
microtubule associated monooxygenase, calponin and LIM domain containing 2a |
chr7_-_41858513 | 7.69 |
ENSDART00000109918
|
mylk3
|
myosin light chain kinase 3 |
chr8_+_45294767 | 7.68 |
ENSDART00000191527
|
ubap2b
|
ubiquitin associated protein 2b |
chr8_+_4337312 | 7.55 |
ENSDART00000182228
|
myl2b
|
myosin, light chain 2b, regulatory, cardiac, slow |
chr14_-_9281232 | 7.52 |
ENSDART00000054693
|
asb12b
|
ankyrin repeat and SOCS box-containing 12b |
chr17_+_23462972 | 7.49 |
ENSDART00000112959
ENSDART00000192168 |
ankrd1a
|
ankyrin repeat domain 1a (cardiac muscle) |
chr25_-_6557854 | 7.34 |
ENSDART00000181740
|
cspg4
|
chondroitin sulfate proteoglycan 4 |
chr16_-_42894628 | 7.32 |
ENSDART00000045600
|
hfe2
|
hemochromatosis type 2 |
chr13_-_1349922 | 7.25 |
ENSDART00000140970
|
si:ch73-52p7.1
|
si:ch73-52p7.1 |
chr8_+_44926946 | 7.19 |
ENSDART00000098567
|
zgc:154046
|
zgc:154046 |
chr18_+_23218980 | 7.18 |
ENSDART00000185014
|
mef2aa
|
myocyte enhancer factor 2aa |
chr6_+_49028874 | 7.14 |
ENSDART00000175254
|
slc16a1a
|
solute carrier family 16 (monocarboxylate transporter), member 1a |
chr2_-_24289641 | 7.11 |
ENSDART00000128784
ENSDART00000123565 ENSDART00000141922 ENSDART00000184550 ENSDART00000191469 |
myh7l
|
myosin heavy chain 7-like |
chr5_+_15203421 | 7.06 |
ENSDART00000040826
|
tbx1
|
T-box 1 |
chr11_+_31285127 | 7.01 |
ENSDART00000160154
|
si:dkey-238i5.2
|
si:dkey-238i5.2 |
chr4_-_20181964 | 6.99 |
ENSDART00000022539
|
fgl2a
|
fibrinogen-like 2a |
chr12_-_25380028 | 6.94 |
ENSDART00000142674
|
zfp36l2
|
zinc finger protein 36, C3H type-like 2 |
chr6_-_39051319 | 6.94 |
ENSDART00000155093
|
tns2b
|
tensin 2b |
chr16_-_24642814 | 6.90 |
ENSDART00000153987
ENSDART00000154319 |
fxyd6l
|
FXYD domain containing ion transport regulator 6 like |
chr21_+_10866421 | 6.80 |
ENSDART00000137858
|
alpk2
|
alpha-kinase 2 |
chr18_+_23249519 | 6.79 |
ENSDART00000005740
ENSDART00000147446 ENSDART00000124818 |
mef2aa
|
myocyte enhancer factor 2aa |
chr24_-_41679356 | 6.79 |
ENSDART00000046821
|
lrrc30a
|
leucine rich repeat containing 30a |
chr20_-_49681850 | 6.73 |
ENSDART00000025926
|
col12a1b
|
collagen, type XII, alpha 1b |
chr22_+_11756040 | 6.70 |
ENSDART00000105808
|
krt97
|
keratin 97 |
chr2_+_50999477 | 6.66 |
ENSDART00000190111
|
eef1da
|
eukaryotic translation elongation factor 1 delta a (guanine nucleotide exchange protein) |
chr4_-_78026285 | 6.64 |
ENSDART00000168273
|
CCT2
|
chaperonin containing TCP1 subunit 2 |
chr4_-_4834347 | 6.63 |
ENSDART00000141803
|
coa6
|
cytochrome c oxidase assembly factor 6 |
chr10_+_24468922 | 6.58 |
ENSDART00000008248
ENSDART00000183510 |
slc7a1
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
chr11_-_18705303 | 6.57 |
ENSDART00000059732
|
id1
|
inhibitor of DNA binding 1 |
chr3_-_26122353 | 6.56 |
ENSDART00000111042
ENSDART00000161427 |
hsp70.2
|
heat shock cognate 70-kd protein, tandem duplicate 2 |
chr23_-_9925568 | 6.51 |
ENSDART00000081268
|
si:ch211-220i18.4
|
si:ch211-220i18.4 |
chr14_-_29905962 | 6.44 |
ENSDART00000142605
|
sorbs2b
|
sorbin and SH3 domain containing 2b |
chr5_-_34997630 | 6.35 |
ENSDART00000170684
|
btf3
|
basic transcription factor 3 |
chr19_+_24488403 | 6.17 |
ENSDART00000052421
|
txnipa
|
thioredoxin interacting protein a |
chr20_-_54208344 | 6.11 |
ENSDART00000169386
|
faua
|
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed a |
chr3_-_31783737 | 6.08 |
ENSDART00000090809
|
kcnh6a
|
potassium voltage-gated channel, subfamily H (eag-related), member 6a |
chr7_+_55112922 | 6.04 |
ENSDART00000073549
|
snai3
|
snail family zinc finger 3 |
chr6_-_10912424 | 6.02 |
ENSDART00000036456
|
cycsb
|
cytochrome c, somatic b |
chr10_-_13178853 | 5.97 |
ENSDART00000163740
ENSDART00000166327 ENSDART00000160265 ENSDART00000164299 |
musk
|
muscle, skeletal, receptor tyrosine kinase |
chr3_+_13559199 | 5.93 |
ENSDART00000166547
|
si:ch73-106n3.1
|
si:ch73-106n3.1 |
chr24_+_19518570 | 5.82 |
ENSDART00000056081
|
sulf1
|
sulfatase 1 |
chr11_+_21050326 | 5.73 |
ENSDART00000065984
|
zgc:113307
|
zgc:113307 |
chr1_-_51734524 | 5.70 |
ENSDART00000109640
ENSDART00000122628 |
junba
|
JunB proto-oncogene, AP-1 transcription factor subunit a |
chr13_-_37615029 | 5.59 |
ENSDART00000111199
|
si:dkey-188i13.6
|
si:dkey-188i13.6 |
chr4_+_8670662 | 5.55 |
ENSDART00000168768
|
adipor2
|
adiponectin receptor 2 |
chr14_-_17659420 | 5.55 |
ENSDART00000165566
|
si:ch211-159i8.4
|
si:ch211-159i8.4 |
chr3_+_2669813 | 5.52 |
ENSDART00000014205
|
CR388047.1
|
|
chr19_-_15281996 | 5.52 |
ENSDART00000103784
|
edn2
|
endothelin 2 |
chr17_+_132555 | 5.48 |
ENSDART00000158159
|
zgc:77287
|
zgc:77287 |
chr3_-_22242868 | 5.47 |
ENSDART00000184511
ENSDART00000191558 ENSDART00000179846 |
myl4
|
myosin, light chain 4, alkali; atrial, embryonic |
chr17_-_45370200 | 5.46 |
ENSDART00000186208
|
znf106a
|
zinc finger protein 106a |
chr16_+_35905031 | 5.45 |
ENSDART00000162411
|
sh3d21
|
SH3 domain containing 21 |
chr19_-_7450796 | 5.45 |
ENSDART00000104750
|
mllt11
|
MLLT11, transcription factor 7 cofactor |
chr1_+_27690 | 5.41 |
ENSDART00000162928
|
eed
|
embryonic ectoderm development |
chr8_+_4798158 | 5.39 |
ENSDART00000031650
|
hsp70l
|
heat shock cognate 70-kd protein, like |
chr6_-_48082525 | 5.39 |
ENSDART00000192049
|
slc2a1b
|
solute carrier family 2 (facilitated glucose transporter), member 1b |
chr7_+_22718251 | 5.39 |
ENSDART00000027718
ENSDART00000143341 |
fxr2
|
fragile X mental retardation, autosomal homolog 2 |
chr23_+_19790962 | 5.39 |
ENSDART00000142228
|
flna
|
filamin A, alpha (actin binding protein 280) |
chr1_+_55002583 | 5.37 |
ENSDART00000037250
|
si:ch211-196h16.12
|
si:ch211-196h16.12 |
chr21_-_217589 | 5.36 |
ENSDART00000185017
|
CZQB01146713.1
|
|
chr11_+_27364338 | 5.34 |
ENSDART00000186759
|
fbln2
|
fibulin 2 |
chr2_-_23778180 | 5.34 |
ENSDART00000136782
|
si:dkey-24c2.7
|
si:dkey-24c2.7 |
chr12_+_28749189 | 5.30 |
ENSDART00000013980
|
tbx21
|
T-box 21 |
chr10_-_8294965 | 5.28 |
ENSDART00000167380
|
plpp1a
|
phospholipid phosphatase 1a |
chr24_+_19518303 | 5.26 |
ENSDART00000027022
ENSDART00000056080 |
sulf1
|
sulfatase 1 |
chr2_+_50999675 | 5.26 |
ENSDART00000158064
ENSDART00000165746 ENSDART00000163917 ENSDART00000172038 ENSDART00000169048 ENSDART00000164775 |
eef1da
|
eukaryotic translation elongation factor 1 delta a (guanine nucleotide exchange protein) |
chr5_+_6670945 | 5.21 |
ENSDART00000185686
|
pxna
|
paxillin a |
chr10_-_8295294 | 5.12 |
ENSDART00000075412
ENSDART00000163803 |
plpp1a
|
phospholipid phosphatase 1a |
chr7_+_49715750 | 5.11 |
ENSDART00000019446
|
ascl1b
|
achaete-scute family bHLH transcription factor 1b |
chr22_+_18477934 | 5.10 |
ENSDART00000132684
|
cilp2
|
cartilage intermediate layer protein 2 |
chr3_-_31784082 | 5.07 |
ENSDART00000134201
|
kcnh6a
|
potassium voltage-gated channel, subfamily H (eag-related), member 6a |
chr17_+_53311243 | 5.04 |
ENSDART00000160241
ENSDART00000160009 ENSDART00000162239 |
asb2b
|
ankyrin repeat and SOCS box containing 2b |
chr25_-_3549321 | 5.04 |
ENSDART00000181214
ENSDART00000160600 |
hdhd5
|
haloacid dehalogenase like hydrolase domain containing 5 |
chr15_-_4528326 | 4.98 |
ENSDART00000158122
ENSDART00000155619 ENSDART00000128602 |
tfdp2
|
transcription factor Dp-2 |
chr5_+_64900223 | 4.91 |
ENSDART00000191677
|
ptgs1
|
prostaglandin-endoperoxide synthase 1 |
chr23_+_43950674 | 4.91 |
ENSDART00000167813
|
corin
|
corin, serine peptidase |
chr4_-_18211 | 4.87 |
ENSDART00000171737
|
ptpn12
|
protein tyrosine phosphatase, non-receptor type 12 |
chr9_-_105135 | 4.86 |
ENSDART00000180126
|
FQ377903.3
|
|
chr21_-_7265219 | 4.85 |
ENSDART00000158852
|
egfl7
|
EGF-like-domain, multiple 7 |
chr3_-_19368435 | 4.81 |
ENSDART00000132987
|
s1pr5a
|
sphingosine-1-phosphate receptor 5a |
chr17_-_14876758 | 4.80 |
ENSDART00000155857
|
nid2a
|
nidogen 2a (osteonidogen) |
chr16_-_25233515 | 4.80 |
ENSDART00000058943
|
zgc:110182
|
zgc:110182 |
chr5_+_23630384 | 4.79 |
ENSDART00000013745
|
cx39.9
|
connexin 39.9 |
chr14_-_32884138 | 4.72 |
ENSDART00000105726
|
slc25a5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
chr5_+_37785152 | 4.69 |
ENSDART00000053511
ENSDART00000189812 |
myo1ca
|
myosin Ic, paralog a |
chr7_+_13756374 | 4.69 |
ENSDART00000180808
|
rasl12
|
RAS-like, family 12 |
chr5_-_52569014 | 4.68 |
ENSDART00000165616
|
mamdc2a
|
MAM domain containing 2a |
chr1_-_11075403 | 4.68 |
ENSDART00000102903
ENSDART00000170290 |
dmd
|
dystrophin |
chr5_-_48307804 | 4.65 |
ENSDART00000182831
ENSDART00000186920 ENSDART00000183585 |
mef2cb
|
myocyte enhancer factor 2cb |
chr3_-_34561624 | 4.64 |
ENSDART00000129313
|
sept9a
|
septin 9a |
chr17_+_15041647 | 4.60 |
ENSDART00000108999
|
samd4a
|
sterile alpha motif domain containing 4A |
chr23_-_18057553 | 4.53 |
ENSDART00000173102
ENSDART00000058742 |
zgc:92287
|
zgc:92287 |
chr9_+_22764235 | 4.52 |
ENSDART00000090875
|
tnfaip6
|
tumor necrosis factor, alpha-induced protein 6 |
chr7_+_73690366 | 4.47 |
ENSDART00000191494
ENSDART00000123429 ENSDART00000173403 |
si:dkey-46i9.6
|
si:dkey-46i9.6 |
chr6_+_43234213 | 4.47 |
ENSDART00000112474
|
arl6ip5a
|
ADP-ribosylation factor-like 6 interacting protein 5a |
chr10_+_26871751 | 4.42 |
ENSDART00000089205
|
ehbp1l1b
|
EH domain binding protein 1-like 1b |
chr14_+_6159162 | 4.42 |
ENSDART00000128638
|
bscl2l
|
Bernardinelli-Seip congenital lipodystrophy 2, like |
chr19_+_31044487 | 4.41 |
ENSDART00000143494
|
ankmy2b
|
ankyrin repeat and MYND domain containing 2b |
chr12_+_18768021 | 4.35 |
ENSDART00000153111
|
mkl1b
|
megakaryoblastic leukemia (translocation) 1b |
chr22_+_11775269 | 4.30 |
ENSDART00000140272
|
krt96
|
keratin 96 |
chr11_+_21053488 | 4.30 |
ENSDART00000189860
|
zgc:113307
|
zgc:113307 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.2 | 39.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
12.3 | 61.4 | GO:0003210 | cardiac atrium formation(GO:0003210) |
6.5 | 19.5 | GO:0065001 | specification of axis polarity(GO:0065001) |
6.0 | 18.0 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
5.5 | 43.7 | GO:0003209 | cardiac atrium morphogenesis(GO:0003209) |
5.4 | 21.8 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
3.8 | 22.8 | GO:0071691 | cardiac muscle thin filament assembly(GO:0071691) |
3.6 | 39.6 | GO:0006735 | glucose catabolic process(GO:0006007) NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
3.5 | 31.5 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
3.4 | 44.8 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
2.8 | 11.1 | GO:0060306 | regulation of membrane repolarization(GO:0060306) regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) regulation of cardiac muscle cell membrane repolarization(GO:0099623) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
2.8 | 16.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.6 | 29.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
2.6 | 36.9 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
2.5 | 17.2 | GO:0033292 | T-tubule organization(GO:0033292) |
2.5 | 19.7 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
2.4 | 7.1 | GO:0043282 | regulation of organ formation(GO:0003156) pharyngeal muscle development(GO:0043282) |
1.9 | 14.9 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) regulation of myotome development(GO:2000290) |
1.8 | 16.6 | GO:2001240 | histone dephosphorylation(GO:0016576) negative regulation of signal transduction in absence of ligand(GO:1901099) regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
1.8 | 12.7 | GO:0034389 | lipid particle organization(GO:0034389) |
1.8 | 9.1 | GO:0097272 | ammonia homeostasis(GO:0097272) |
1.6 | 13.1 | GO:0032889 | regulation of vacuole fusion, non-autophagic(GO:0032889) |
1.6 | 8.0 | GO:1903573 | negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
1.5 | 13.6 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.5 | 13.5 | GO:0007525 | somatic muscle development(GO:0007525) |
1.5 | 19.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.4 | 7.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
1.4 | 4.3 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
1.4 | 5.5 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) vein smooth muscle contraction(GO:0014826) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.3 | 3.9 | GO:0006600 | creatine metabolic process(GO:0006600) creatine biosynthetic process(GO:0006601) |
1.3 | 7.7 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.2 | 22.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.2 | 4.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.2 | 9.7 | GO:0006537 | glutamate biosynthetic process(GO:0006537) glutamine catabolic process(GO:0006543) |
1.2 | 2.4 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
1.2 | 4.7 | GO:0015859 | intracellular nucleoside transport(GO:0015859) purine nucleoside transmembrane transport(GO:0015860) purine nucleotide transport(GO:0015865) ATP transport(GO:0015867) purine ribonucleotide transport(GO:0015868) adenine nucleotide transport(GO:0051503) mitochondrial ATP transmembrane transport(GO:1990544) |
1.2 | 13.8 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
1.1 | 7.9 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
1.1 | 26.0 | GO:0055008 | cardiac muscle tissue morphogenesis(GO:0055008) |
1.1 | 5.4 | GO:0090199 | regulation of mitochondrial membrane potential(GO:0051881) regulation of release of cytochrome c from mitochondria(GO:0090199) positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
1.0 | 13.9 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
1.0 | 1.0 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.9 | 36.1 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.9 | 3.5 | GO:0035553 | oxidative single-stranded RNA demethylation(GO:0035553) |
0.8 | 2.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.8 | 4.0 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.8 | 19.8 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.8 | 3.8 | GO:0051103 | DNA ligation(GO:0006266) immunoglobulin V(D)J recombination(GO:0033152) DNA ligation involved in DNA repair(GO:0051103) |
0.7 | 5.2 | GO:0061055 | myotome development(GO:0061055) |
0.7 | 10.9 | GO:0042026 | protein refolding(GO:0042026) |
0.7 | 8.6 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.7 | 8.3 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.7 | 2.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.7 | 4.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.7 | 3.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.7 | 1.3 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.6 | 2.5 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.6 | 3.0 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.6 | 4.2 | GO:0040016 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) embryonic cleavage(GO:0040016) |
0.6 | 2.9 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.6 | 1.7 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.6 | 3.9 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.5 | 5.6 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.5 | 12.8 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.5 | 1.4 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
0.5 | 8.5 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.5 | 1.9 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.5 | 9.9 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.5 | 49.2 | GO:0048738 | cardiac muscle tissue development(GO:0048738) |
0.5 | 4.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.4 | 2.2 | GO:0008591 | regulation of Wnt signaling pathway, calcium modulating pathway(GO:0008591) positive regulation of convergent extension involved in gastrulation(GO:1904105) |
0.4 | 11.3 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.4 | 22.2 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.4 | 16.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.4 | 10.7 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.4 | 1.3 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.4 | 24.8 | GO:0051693 | actin filament capping(GO:0051693) |
0.4 | 1.2 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.4 | 6.7 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.4 | 1.9 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.4 | 2.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 1.7 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.3 | 2.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 2.7 | GO:0035479 | angioblast cell migration from lateral mesoderm to midline(GO:0035479) |
0.3 | 7.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 3.3 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.3 | 7.9 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
0.3 | 8.9 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.3 | 8.1 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.3 | 1.4 | GO:0016037 | light absorption(GO:0016037) |
0.3 | 0.9 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.3 | 5.7 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 1.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.3 | 2.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 6.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 4.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 2.2 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.3 | 6.9 | GO:0007286 | spermatid development(GO:0007286) |
0.3 | 0.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 0.5 | GO:0048660 | regulation of smooth muscle cell proliferation(GO:0048660) negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.3 | 2.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 3.0 | GO:0001840 | neural plate development(GO:0001840) |
0.2 | 1.0 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.2 | 2.0 | GO:0061709 | reticulophagy(GO:0061709) |
0.2 | 0.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 0.7 | GO:0001113 | DNA-templated transcriptional open complex formation(GO:0001112) transcriptional open complex formation at RNA polymerase II promoter(GO:0001113) protein-DNA complex remodeling(GO:0001120) |
0.2 | 3.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 2.4 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 3.5 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.2 | 7.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 3.9 | GO:0035803 | binding of sperm to zona pellucida(GO:0007339) egg coat formation(GO:0035803) regulation of acrosome reaction(GO:0060046) positive regulation of acrosome reaction(GO:2000344) |
0.2 | 4.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 4.0 | GO:0002574 | thrombocyte differentiation(GO:0002574) |
0.2 | 15.4 | GO:0030239 | myofibril assembly(GO:0030239) |
0.2 | 0.6 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.2 | 0.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 1.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 2.0 | GO:0031269 | pseudopodium organization(GO:0031268) pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 1.4 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.2 | 1.2 | GO:0035332 | positive regulation of hippo signaling(GO:0035332) |
0.2 | 3.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 11.9 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.2 | 3.7 | GO:0097192 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.2 | 0.5 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.2 | 1.8 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 3.6 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 1.8 | GO:0060612 | adipose tissue development(GO:0060612) |
0.2 | 1.1 | GO:0038065 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
0.2 | 2.1 | GO:0033198 | response to ATP(GO:0033198) |
0.2 | 3.3 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 0.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 5.5 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.2 | 1.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 2.0 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
0.2 | 3.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 1.6 | GO:0061157 | RNA destabilization(GO:0050779) mRNA destabilization(GO:0061157) |
0.2 | 6.8 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.2 | 5.5 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.2 | 1.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 1.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 16.2 | GO:0060047 | heart contraction(GO:0060047) |
0.1 | 1.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 1.2 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) ventral spinal cord interneuron fate commitment(GO:0060579) |
0.1 | 3.4 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.1 | 2.3 | GO:0051899 | membrane depolarization(GO:0051899) |
0.1 | 3.3 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.1 | 8.7 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 2.0 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.1 | 1.0 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
0.1 | 3.4 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.1 | 10.4 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.8 | GO:0032447 | protein urmylation(GO:0032447) |
0.1 | 0.6 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 4.3 | GO:0051051 | negative regulation of transport(GO:0051051) |
0.1 | 9.7 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.1 | 8.7 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 5.4 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 10.2 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.1 | 2.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) |
0.1 | 4.4 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.1 | 1.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 1.4 | GO:0051122 | lipoxygenase pathway(GO:0019372) linoleic acid metabolic process(GO:0043651) hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 4.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 7.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 3.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.8 | GO:1900186 | optomotor response(GO:0071632) caveolin-mediated endocytosis(GO:0072584) negative regulation of clathrin-mediated endocytosis(GO:1900186) regulation of caveolin-mediated endocytosis(GO:2001286) negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.1 | 4.6 | GO:0021575 | hindbrain morphogenesis(GO:0021575) |
0.1 | 7.7 | GO:0031101 | fin regeneration(GO:0031101) |
0.1 | 0.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) single-organism membrane invagination(GO:1902534) |
0.1 | 0.7 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 3.0 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) negative regulation of vasculature development(GO:1901343) negative regulation of blood vessel morphogenesis(GO:2000181) |
0.1 | 0.6 | GO:0032728 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.8 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 1.5 | GO:0090481 | pyrimidine nucleotide-sugar transport(GO:0015781) pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 2.4 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 1.1 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous antigen(GO:0019883) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 5.9 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.1 | 0.7 | GO:0030104 | water homeostasis(GO:0030104) |
0.1 | 1.2 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) regulation of ERBB signaling pathway(GO:1901184) |
0.1 | 0.6 | GO:0008406 | gonad development(GO:0008406) |
0.1 | 1.2 | GO:0045471 | response to ethanol(GO:0045471) |
0.1 | 5.8 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 1.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 1.5 | GO:0034661 | ncRNA catabolic process(GO:0034661) |
0.1 | 0.9 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 1.0 | GO:0042698 | ovarian follicle development(GO:0001541) ovulation cycle process(GO:0022602) ovulation cycle(GO:0042698) |
0.1 | 7.3 | GO:0032835 | glomerulus development(GO:0032835) |
0.1 | 0.3 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 3.2 | GO:0006090 | pyruvate metabolic process(GO:0006090) |
0.1 | 3.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 2.5 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 1.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 4.8 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 3.5 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.5 | GO:0000455 | enzyme-directed rRNA pseudouridine synthesis(GO:0000455) |
0.1 | 1.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 1.7 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 2.4 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 1.0 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 0.7 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.9 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.3 | GO:0042311 | vasodilation(GO:0042311) |
0.1 | 2.1 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 2.4 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 2.0 | GO:0045103 | intermediate filament-based process(GO:0045103) intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 0.6 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
0.1 | 1.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 1.4 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 1.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.9 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.2 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 5.4 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 4.4 | GO:0006342 | chromatin silencing(GO:0006342) |
0.1 | 2.8 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of chemotaxis(GO:0050922) negative regulation of axon guidance(GO:1902668) |
0.1 | 2.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 33.7 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.1 | 1.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.9 | GO:0030032 | lamellipodium assembly(GO:0030032) lamellipodium organization(GO:0097581) |
0.1 | 4.9 | GO:0046474 | glycerophospholipid biosynthetic process(GO:0046474) |
0.0 | 0.7 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.0 | 1.7 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.0 | 0.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0002363 | CD4-positive, alpha-beta T cell differentiation involved in immune response(GO:0002294) T-helper cell lineage commitment(GO:0002295) T cell lineage commitment(GO:0002360) alpha-beta T cell lineage commitment(GO:0002363) T-helper cell differentiation(GO:0042093) CD4-positive, alpha-beta T cell differentiation(GO:0043367) CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) T-helper 17 type immune response(GO:0072538) T-helper 17 cell differentiation(GO:0072539) T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 1.7 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 8.9 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 3.5 | GO:0030178 | negative regulation of Wnt signaling pathway(GO:0030178) |
0.0 | 1.8 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.6 | GO:0030534 | adult behavior(GO:0030534) |
0.0 | 1.5 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 1.2 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.5 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 1.5 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.7 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 2.7 | GO:0008544 | epidermis development(GO:0008544) |
0.0 | 0.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 1.8 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 0.5 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.0 | 0.3 | GO:0048798 | swim bladder maturation(GO:0048796) swim bladder inflation(GO:0048798) |
0.0 | 0.9 | GO:0097191 | extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 2.2 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.0 | 1.8 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.5 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.0 | 0.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 2.9 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 1.0 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 1.0 | GO:0007283 | spermatogenesis(GO:0007283) |
0.0 | 1.7 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.0 | 0.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 111.6 | GO:0031672 | A band(GO:0031672) |
3.6 | 39.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
2.3 | 11.4 | GO:0008091 | spectrin(GO:0008091) |
1.9 | 39.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
1.7 | 11.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.6 | 13.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.6 | 144.2 | GO:0030018 | Z disc(GO:0030018) |
1.4 | 59.8 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
1.4 | 59.0 | GO:0005861 | troponin complex(GO:0005861) |
1.3 | 5.4 | GO:1902737 | dendritic spine neck(GO:0044326) dendritic filopodium(GO:1902737) |
1.3 | 3.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.2 | 4.7 | GO:0060171 | stereocilium membrane(GO:0060171) |
1.1 | 12.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
1.1 | 6.3 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.8 | 8.9 | GO:0061617 | MICOS complex(GO:0061617) |
0.7 | 12.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.7 | 2.0 | GO:1990879 | CST complex(GO:1990879) |
0.6 | 13.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.5 | 2.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.5 | 3.0 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.5 | 2.0 | GO:0097519 | DNA recombinase complex(GO:0097519) |
0.5 | 4.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 3.7 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.4 | 5.1 | GO:0002102 | podosome(GO:0002102) |
0.4 | 2.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 1.7 | GO:1990071 | TRAPPII protein complex(GO:1990071) |
0.3 | 3.7 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 40.7 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.3 | 0.9 | GO:0033391 | chromatoid body(GO:0033391) |
0.3 | 7.5 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 0.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 7.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 1.2 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 9.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 15.3 | GO:0005882 | intermediate filament(GO:0005882) |
0.2 | 2.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 17.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.9 | GO:0070390 | transcription export complex 2(GO:0070390) |
0.2 | 4.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 1.0 | GO:0033557 | Slx1-Slx4 complex(GO:0033557) |
0.1 | 3.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.7 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.1 | 1.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 3.4 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 2.0 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.1 | 1.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 1.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 11.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 4.2 | GO:0031105 | septin ring(GO:0005940) septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.1 | 2.1 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 1.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 5.6 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 34.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 3.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 5.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 2.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) sodium channel complex(GO:0034706) |
0.1 | 1.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 1.9 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 3.5 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 25.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 7.7 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.3 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.1 | 8.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 2.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 5.0 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.3 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 3.9 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 1.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 6.0 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 5.5 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.6 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 14.4 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 3.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 1.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 4.1 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.9 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 1.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 1.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.7 | GO:0045180 | basal part of cell(GO:0045178) basal cortex(GO:0045180) |
0.0 | 3.7 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.4 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 1.8 | GO:0005814 | centriole(GO:0005814) |
0.0 | 1.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 3.9 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 41.1 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 3.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.7 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.7 | GO:0030286 | dynein complex(GO:0030286) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.9 | 31.5 | GO:0071253 | connexin binding(GO:0071253) |
7.5 | 52.5 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) |
5.6 | 61.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
3.9 | 38.5 | GO:0051373 | telethonin binding(GO:0031433) FATZ binding(GO:0051373) |
3.6 | 39.6 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
3.5 | 10.4 | GO:0000810 | diacylglycerol diphosphate phosphatase activity(GO:0000810) |
3.3 | 49.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
2.9 | 8.7 | GO:1990715 | mRNA CDS binding(GO:1990715) sequence-specific mRNA binding(GO:1990825) |
2.8 | 16.5 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
2.7 | 10.8 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
2.4 | 19.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.8 | 7.2 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
1.7 | 12.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.6 | 13.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.4 | 19.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.4 | 5.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.4 | 8.2 | GO:0048156 | tau protein binding(GO:0048156) |
1.4 | 15.0 | GO:0031013 | troponin C binding(GO:0030172) troponin I binding(GO:0031013) |
1.3 | 16.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.2 | 13.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.2 | 4.9 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
1.2 | 12.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
1.2 | 4.7 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) |
1.2 | 15.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.1 | 26.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
1.1 | 23.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.1 | 5.6 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
1.1 | 9.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.9 | 4.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.9 | 3.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.9 | 10.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.9 | 14.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.9 | 3.5 | GO:1990931 | RNA N6-methyladenosine dioxygenase activity(GO:1990931) |
0.8 | 2.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.8 | 3.2 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.8 | 5.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.8 | 29.2 | GO:0005518 | collagen binding(GO:0005518) |
0.7 | 10.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.7 | 2.7 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.6 | 4.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.6 | 7.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.6 | 4.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.6 | 2.9 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.5 | 2.1 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.5 | 2.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.5 | 2.0 | GO:1990238 | double-stranded DNA endodeoxyribonuclease activity(GO:1990238) |
0.5 | 1.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.5 | 1.4 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.4 | 21.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.4 | 7.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.4 | 8.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.4 | 2.3 | GO:0010858 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
0.4 | 4.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.4 | 3.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.4 | 9.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.3 | 2.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 18.5 | GO:0044325 | ion channel binding(GO:0044325) |
0.3 | 2.6 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.3 | 1.9 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 1.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 7.8 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 4.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 3.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.3 | 4.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 3.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 0.9 | GO:1990174 | phosphodiesterase decapping endonuclease activity(GO:1990174) |
0.3 | 11.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 1.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 11.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 1.8 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 4.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 89.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 4.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 4.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 1.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 5.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 3.9 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 1.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 1.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 3.9 | GO:0072542 | phosphatase activator activity(GO:0019211) protein phosphatase activator activity(GO:0072542) |
0.2 | 0.8 | GO:0008459 | chondroitin 6-sulfotransferase activity(GO:0008459) |
0.2 | 4.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 6.2 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 16.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 2.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 49.5 | GO:0003779 | actin binding(GO:0003779) |
0.2 | 3.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 1.0 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 1.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 3.5 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 0.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 1.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 1.5 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 0.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 10.2 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 0.7 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.1 | 1.5 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 1.7 | GO:0043028 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 1.8 | GO:0019210 | protein kinase inhibitor activity(GO:0004860) kinase inhibitor activity(GO:0019210) |
0.1 | 4.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 3.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 1.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 6.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 5.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 2.4 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 1.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 48.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 3.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.6 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.6 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 7.9 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.8 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 2.3 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 1.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 18.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 2.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 2.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 0.7 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 1.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 5.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 5.9 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.1 | 0.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 41.8 | GO:0046983 | protein dimerization activity(GO:0046983) |
0.1 | 2.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 1.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 1.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 1.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 2.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 3.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 12.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 2.6 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 2.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.7 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 2.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 1.2 | GO:0015379 | cation:chloride symporter activity(GO:0015377) potassium:chloride symporter activity(GO:0015379) |
0.1 | 1.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 1.6 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 1.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 2.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 17.4 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.2 | GO:0030504 | inorganic diphosphate transmembrane transporter activity(GO:0030504) |
0.0 | 1.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 1.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.8 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 5.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 2.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.7 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.0 | 1.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 1.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 1.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 1.2 | GO:0030295 | kinase activator activity(GO:0019209) protein kinase activator activity(GO:0030295) |
0.0 | 1.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 2.7 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 3.7 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 12.1 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.3 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.0 | 0.7 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 13.5 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 1.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
0.0 | 1.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 29.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.7 | 23.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.6 | 13.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 7.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.5 | 18.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 10.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.4 | 3.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 2.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 6.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 13.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 17.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 5.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 8.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 4.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 1.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 3.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 2.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 3.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 4.8 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 6.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 2.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 2.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 2.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 3.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 9.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.8 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 1.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 49.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.6 | 12.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.4 | 18.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.9 | 2.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.8 | 12.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.6 | 3.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.5 | 13.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.5 | 9.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 14.8 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.4 | 1.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.3 | 11.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 6.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.3 | 3.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 1.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 2.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 2.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 2.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 5.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 2.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 8.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 4.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 1.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 2.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 4.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 4.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 2.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 6.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 3.7 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.1 | 1.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.6 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 2.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 6.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 5.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 3.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.7 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 4.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 2.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 2.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 1.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.9 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 1.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.6 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.7 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |